TBX3 and breast cancer: Large‐scale genomics consortia have previously identified a number of breast cancer driver genes, including TBX327; indeed, TBX3 mutations account for ulnar–mammary syndrome 28, and, in breast cancer, appear to result in the loss of transcriptional repressor function 29.